Product Information
- N-Ethyl-N-methylcarbamic acid (3R)-2,3-dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutanedioateTV 3326
- (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl ethyl(methyl)carbamate 2,3-dihydroxybutanedioate (2:1)
- Carbamic acid, N-ethyl-N-methyl-, (3R)-2,3-dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl ester, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Carbamic acid, ethylmethyl-, (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Ethylmethyl-carbamic acid (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- Tv 3326
Ladostigil tartrate is an aminopyridine drug that has been used to treat neurodegenerative diseases, such as Alzheimer's disease. Ladostigil tartrate is a pro-drug of carbamic acid and butyrylcholinesterase inhibitor. This medication binds to the active site of acetylcholine esterase (AChE) and blocks its activity. This allows more acetylcholine to accumulate in the synapses, which results in increased stimulation of postsynaptic receptors. Ladostigil tartrate also has neuroprotective effects and has been shown to reduce microglial activation and pro-inflammatory cytokines in mice models for Alzheimer's disease.
Chemical properties
Technical inquiry about: 3D-FL24829 Ladostigil tartrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
